Related Experiment Video
Updated: Feb 2, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function
Cheng Guo1, Yinhu Li2, Peipei Wang1
1Department of Pediatrics, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
Insights
Infants with cholestasis show altered gut microbiota (GM) diversity and composition. Specific bacterial biomarkers can distinguish cholestatic infants, highlighting GM
Area of Science:
- Microbiology
- Hepatology
- Pediatrics
Background:
- Cholestasis is a significant infant liver disease with rising morbidity.
- Gut microbiota (GM) is increasingly linked to various liver diseases.
- GM alterations and their correlation with hepatic function in cholestatic infants are uninvestigated.
Purpose of the Study:
- To investigate gut microbiota discrepancies in cholestatic infants compared to healthy infants.
- To explore the correlation between gut microbiota composition and indicators of hepatic function.
- To identify potential gut microbiota biomarkers for infantile cholestasis.
Main Methods:
- 16S rDNA sequencing was used to analyze gut microbiota in 43 cholestatic and 37 healthy infants.
- Analysis included bacterial community diversity, genus abundance, co-occurrence networks, and functional prediction (KEGG annotation).
- Correlation analysis was performed between gut microbiota and hepatic function indicators (bilirubin, GGT).
Main Results:
- Cholestatic infants exhibited significantly lower bacterial diversity and altered abundance of key genera (e.g., Bifidobacterium, Bacteroides).
- Specific genera (Rothia, Eggerthella, Phyllobacterium, Blautia) accurately identified cholestatic infants (AUC > 0.97).
- GM alterations in cholestatic infants were linked to lipid metabolism, xenobiotic biodegradation, and impaired amino acid/vitamin metabolism, with significant correlations to bilirubin and GGT levels.
Conclusions:
- Gut microbiota composition is significantly altered in infants with cholestasis.
- Specific gut microbes serve as valuable biomarkers for diagnosing infantile cholestasis.
- These findings provide a basis for gut microbiota-targeted interventions in treating infantile cholestasis.
Abstract:
Cholestasis is a major hepatic disease in infants, with increasing morbidity in recent years. Accumulating evidence has revealed that the gut microbiota (GM) is associated with liver diseases, such as non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma. However, GM alterations in cholestatic infants and the correlation between the GM and hepatic functions remain uninvestigated. In this study, 43 cholestatic infants (IC group) and 37 healthy infants (H group) were enrolled to detect GM discrepancies using 16S rDNA analysis. The diversity in the bacterial community was significantly lower in the IC group than that in the H group (P = 0.013). After determining the top 10 abundant genera of microbes in the IC and H groups, we found that 13 of them were differentially enriched, including Bifidobacterium, Bacteroides, Streptococcus, Enterococcus, and Staphylococcus. As compared with the H group, the IC group had a more complex GM co-occurrence network featured by three core nodes: Phyllobacterium, Ruminococcus, and Anaerostipes. In addition, the positive correlation between Faecalibacterium and Erysipelatoclostridium (r = 0.689, P = 0.000, FDR = 0.009) was not observed in the IC patients. Using the GM composition, the cholestatic patients can be distinguished from healthy infants with high accuracy [areas under receiver operating curve (AUC) > 0.97], wherein Rothia, Eggerthella, Phyllobacterium, and Blautia are identified as valuable biomarkers. Using KEGG annotation, we identified 32 functional categories with significant difference in enrichment of the GM of IC patients, including IC-enriched functional categories that were related to lipid metabolism, biodegradation and metabolism of xenobiotics, and various diseases. In contrast, the number of functions associated with amino acid metabolism, nucleotide metabolism, and vitamins metabolism was reduced in the IC patients. We also identified significant correlation between GM composition and indicators of hepatic function. Megasphaera positively correlated with total bilirubin (r = 0.455, P = 0.002) and direct bilirubin (r = 0.441, P = 0.003), whereas γ-glutamyl transpeptidase was positively associated with Parasutterella (r = 0.466, P = 0.002) and negatively related to Streptococcus (r = -0.450, P = 0.003). This study describes the GM characteristics in the cholestatic infants, illustrates the association between the GM components and the hepatic function, and provides a solid theoretical basis for GM intervention for the treatment of infantile cholestasis.
Related Concept Videos
Correlations
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Correlation
Two variables, for example, a and b, are said to be positively correlated if both variables move in the same direction. In other words, a positive correlation exists between two variables, a and b, if:
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...

